FIELD: medicine.
SUBSTANCE: vaccine strain of A/17/Brisbane/07/28 (H1N1) influenza virus is a reassortant prepared by cross breeding an epidemic A/ Brisbane /59/07 (H1N1) virus and a cold-adapted thermally sensitive A/Leningrad/134/17/57 (H2N2) virus being a human-safe attenuation donor. The A/17/Brisbane/07/28 (H1N1) strain replicates actively in growing chicken embryos at optimum temperature 32°C. The reassortant has inherited the genes coding surface virus antigens - hemagglutinin (HA) and neuraminidase (NA) from an epidemic parent virus, and six genes coding internal non-glycosylated proteins from the attenuation donor. The A/17/Brisbane/07/28 (H1N1) strain is areactogenic for adults and children in intranasal introduction. In reactogenecity, the vaccine strain of A/17/Brisbane/07/28 (H1N1) influenza virus meets the requirements specified in the Manufacturer's Monograph 42-0417-4097-03 to vaccine strains for live dry allantoic influenza vaccine for intranasal application.
EFFECT: strain is characterised by thermal sensitivity and cold adaptation.
1 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
VACCINE STRAIN OF A/17/SOLOMON ISLANDS/06/9 (H1N1) INFLUENZA VIRUS FOR PREPARING LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2010 |
|
RU2422518C1 |
VACCINE STRAIN OF A/17/BRISBANE/07/1 (H3N2) INFLUENZA VIRUS FOR PREPARING LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2010 |
|
RU2416640C1 |
STRAIN OF INFLUENZA VIRUS A/17/VICTORIA/2011/89 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2012 |
|
RU2532844C2 |
STRAIN OF INFLUENZA VIRUS A/17/NEW CALEDONIA/99/145 (H1N1) FOR PRODUCTION OF LIVE (ANTI)-INFLUENZA INTRANASAL VACCINE FOR ADULTS | 2000 |
|
RU2183672C1 |
VACCINE STRAIN OF FLU VIRUS A/17/CALIFORNIA/2009/38 (H1N1) FOR PROFUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2009 |
|
RU2413765C1 |
STRAIN OF INFLUENZA VIRUS A/47/NEW CALEDONIA/99/156 (H1N1) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR CHILDREN | 2000 |
|
RU2185437C1 |
INFLUENZA VIRUS STRAIN A/17/PEKING/95/25 (H1N1) FOR PRODUCTION OF LIVE INFLUENZAL INTRANASAL VACCINE FOR ADULTS | 1999 |
|
RU2159811C1 |
VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2018/8175 (H1N1) PDM09 FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2019 |
|
RU2735291C1 |
REASSORTANT STRAIN OF INFLUENZA A/17/DARWIN/2018/154 (H1N1)PDM09 VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825670C1 |
INFLUENZA VIRUS STRAIN FOR PRODUCING LIVE AND INACTIVATED INFLUENZA VACCINE | 2011 |
|
RU2464309C1 |
Authors
Dates
2011-04-20—Published
2010-01-11—Filed